Details for New Drug Application (NDA): 208314
✉ Email this page to a colleague
The generic ingredient in LORATADINE is loratadine; pseudoephedrine sulfate. There are thirty-nine drug master file entries for this compound. Thirty-two suppliers are listed for this compound. Additional details are available on the loratadine; pseudoephedrine sulfate profile page.
Summary for 208314
Tradename: | LORATADINE |
Applicant: | Aurobindo Pharma Ltd |
Ingredient: | loratadine |
Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 208314
Suppliers and Packaging for NDA: 208314
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
LORATADINE | loratadine | TABLET;ORAL | 208314 | ANDA | WALGREEN CO. | 0363-9603 | 0363-9603-09 | 1 BOTTLE in 1 CARTON (0363-9603-09) / 30 TABLET in 1 BOTTLE |
LORATADINE | loratadine | TABLET;ORAL | 208314 | ANDA | Major Pharmaceuticals | 0904-7426 | 0904-7426-46 | 1 BOTTLE in 1 CARTON (0904-7426-46) / 30 TABLET in 1 BOTTLE |
Profile for product number 001
Active Rx/OTC/Discontinued: | OTC | Dosage: | TABLET;ORAL | Strength | 10MG | ||||
Approval Date: | Apr 16, 2018 | TE: | RLD: | No |
Complete Access Available with Subscription